Status:
RECRUITING
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Coronary Atheroscleroses
Eligibility:
All Genders
18-75 years
Brief Summary
Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improv...
Detailed Description
patients with CTO lesions undergoing PCI at the First Affiliated Hospital of Nanjing Medical University from January 2011 to December 2017 were enrolled. After someone were excluded due to CABG surger...
Eligibility Criteria
Inclusion
- patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017
Exclusion
- (1) patients with ST-segment elevation myocardial infarction (STEMI)
- (2)a history of coronary artery bypass grafting (CABG)
- (3) cardiogenic shock
- (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.
Key Trial Info
Start Date :
September 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 17 2025
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT06542653
Start Date
September 17 2023
End Date
September 17 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210009